Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
226.7 USD | +0.12% | -0.21% | -9.72% |
02:53am | Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate | MT |
Mar. 22 | Truist Securities Cuts Penumbra's Price Target to $280 From $290, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 1.25B | Sales 2025 * | 1.45B | Capitalization | 8.76B |
---|---|---|---|---|---|
Net income 2024 * | 108M | Net income 2025 * | 154M | EV / Sales 2024 * | 6.86 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 353M | EV / Sales 2025 * | 5.8 x |
P/E ratio 2024 * |
82
x | P/E ratio 2025 * |
58
x | Employees | 4,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.18% |
Latest transcript on Penumbra, Inc.
1 day | +2.49% | ||
1 week | -4.23% | ||
Current month | -3.64% | ||
1 month | -2.56% | ||
3 months | -13.00% | ||
6 months | -5.95% | ||
Current year | -10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Arani Bose
FOU | Founder | 62 | 04-06-20 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Maggie Yuen
DFI | Director of Finance/CFO | 52 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Wilder
BRD | Director/Board Member | 60 | 17-01-12 |
Harpreet Grewal
BRD | Director/Board Member | 57 | 15-03-31 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.21% | 17 M€ | -0.46% | ||
1.18% | 2 M€ | -1.17% | - | |
0.33% | 464 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 227.2 | +0.35% | 103 057 |
24-03-27 | 226.4 | +2.49% | 464,660 |
24-03-26 | 220.9 | +0.35% | 928,942 |
24-03-25 | 220.1 | -2.07% | 503,666 |
24-03-22 | 224.7 | -1.24% | 327,984 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.00% | 8.76B | |
+69.30% | 12.06B | |
+23.27% | 7.64B | |
-3.97% | 5.56B | |
-7.90% | 4.87B | |
-2.40% | 4.62B | |
+10.12% | 3.94B | |
-26.99% | 2.75B | |
+3.59% | 2.11B | |
+5.20% | 1.89B |